The agreement, signed on Tuesday, June 11, 2024, aims to foster cooperation between the two countries.
This agreement comes at a time when Rwanda is constructing the BioNtech plant, which will manufacture various vaccines.
IVI is a non-profit organization dedicated to advocacy for vaccine availability and accessibility for all, through collaboration with research institutions, governments, and pharmaceutical companies.
The organization plays a role in the development of new vaccines, testing, and distribution worldwide.
Founded in 1998, IVI is headquartered in Seoul, South Korea.
YOUR OPINION ABOUT THIS ARTICLE
RULES AND REGULATIONS
Do not post comments that are defamatory, divisive and blasphemous.If you wish to receive a quick response to your opinion/comments, please provide your email address in the space provided. Your comments will appear after moderation from IGIHE.com.
In case the above regulations are not observed, your comments might not appear or will be deleted. Thank you!